SEK 155.5
(1.44%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 12.74 Billion SEK | -2.39% |
2022 | 13.05 Billion SEK | 23.23% |
2021 | 10.59 Billion SEK | 155.34% |
2020 | 4.14 Billion SEK | 26.73% |
2019 | 3.27 Billion SEK | 22.74% |
2018 | 2.66 Billion SEK | 41.06% |
2017 | 1.89 Billion SEK | 17.3% |
2016 | 1.61 Billion SEK | 26.25% |
2015 | 1.27 Billion SEK | 98.52% |
2014 | 643.3 Million SEK | 4.91% |
2013 | 613.2 Million SEK | 0.71% |
2012 | 608.9 Million SEK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 13.02 Billion SEK | -1.77% |
2024 Q3 | 12.94 Billion SEK | -0.64% |
2024 Q1 | 13.26 Billion SEK | 4.06% |
2023 Q2 | 13.82 Billion SEK | 4.42% |
2023 Q3 | 13.31 Billion SEK | -3.68% |
2023 FY | 12.74 Billion SEK | -2.39% |
2023 Q4 | 12.74 Billion SEK | -4.31% |
2023 Q1 | 13.24 Billion SEK | 1.42% |
2022 Q3 | 12.91 Billion SEK | 1.73% |
2022 Q2 | 12.69 Billion SEK | 2.59% |
2022 FY | 13.05 Billion SEK | 23.23% |
2022 Q1 | 12.37 Billion SEK | 16.76% |
2022 Q4 | 13.05 Billion SEK | 1.12% |
2021 Q3 | 10.19 Billion SEK | -0.02% |
2021 Q1 | 4.5 Billion SEK | 8.64% |
2021 Q2 | 10.19 Billion SEK | 126.2% |
2021 FY | 10.59 Billion SEK | 155.34% |
2021 Q4 | 10.59 Billion SEK | 3.93% |
2020 Q2 | 3.59 Billion SEK | -0.69% |
2020 FY | 4.14 Billion SEK | 26.73% |
2020 Q4 | 4.14 Billion SEK | 15.3% |
2020 Q3 | 3.59 Billion SEK | 0.06% |
2020 Q1 | 3.62 Billion SEK | 10.62% |
2019 Q3 | 3.24 Billion SEK | 4.47% |
2019 Q4 | 3.27 Billion SEK | 0.81% |
2019 FY | 3.27 Billion SEK | 22.74% |
2019 Q1 | 2.86 Billion SEK | 7.2% |
2019 Q2 | 3.1 Billion SEK | 8.71% |
2018 Q1 | 1.9 Billion SEK | 0.78% |
2018 Q3 | 1.98 Billion SEK | 3.82% |
2018 FY | 2.66 Billion SEK | 41.06% |
2018 Q4 | 2.66 Billion SEK | 34.47% |
2018 Q2 | 1.91 Billion SEK | 0.26% |
2017 Q2 | 1.82 Billion SEK | -1.77% |
2017 Q1 | 1.86 Billion SEK | 18.03% |
2017 FY | 1.89 Billion SEK | 17.3% |
2017 Q4 | 1.89 Billion SEK | 0.44% |
2017 Q3 | 1.88 Billion SEK | 3.01% |
2016 Q4 | 1.57 Billion SEK | 16.82% |
2016 Q3 | 1.34 Billion SEK | -1.21% |
2016 Q1 | 1.27 Billion SEK | -11.56% |
2016 Q2 | 1.36 Billion SEK | 6.98% |
2016 FY | 1.61 Billion SEK | 26.25% |
2015 Q4 | 1.44 Billion SEK | 0.0% |
2015 FY | 1.27 Billion SEK | 98.52% |
2015 Q1 | 643.3 Million SEK | 0.0% |
2014 FY | 643.3 Million SEK | 4.91% |
2013 FY | 613.2 Million SEK | 0.71% |
2012 FY | 608.9 Million SEK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Biotage AB (publ) | 4.93 Billion SEK | -158.467% |
Bonesupport Holding AB (publ) | 688.81 Million SEK | -1750.276% |
Doxa AB (publ) | 3.75 Billion SEK | -239.432% |
Elekta AB (publ) | 31.41 Billion SEK | 59.428% |
iZafe Group AB (publ) | 34.61 Million SEK | -36720.362% |
Ortivus AB (publ) | 72.7 Million SEK | -17429.502% |
Ortivus AB (publ) | 72.7 Million SEK | -17429.502% |
Q-linea AB (publ) | 231.97 Million SEK | -5394.103% |
S2Medical AB (publ) | 21.4 Million SEK | -59435.463% |
Synsam AB (publ) | 8.03 Billion SEK | -58.599% |